Rigel Pharmaceuticals reported $22.88M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Acura Pharmaceuticals ACUR:US 523K 138K
Agenus AGEN:US $ 21.38M 4.73M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Amgen AMGN:US $ 1.31B 79M
Anika Therapeutics ANIK:US $ 17.5M 489K
Applied Genetic Technologies AGTC:US $ 3.68M 207K
Astrazeneca AZN:US 2.99B 412M
AstraZeneca AZN:LN 2.99B 412M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bristol Myers Squibb BMY:US $ 1.79B 95M
Celldex Therapeutics CLDX:US $ 5.82M 1.52M
Chemocentryx CCXI:US $ 19.6M 100K
Daiichi Sankyo 4568:JP 84.5B 5.38B
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Eli Lilly And LLY:US $ 1.58B 107.8M
Flexion Therapeutics FLXN:US $ 26.99M 423K
Halozyme Therapeutics HALO:US $ 13.17M 848K
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Immunogen IMGN:US $ 10.3M 569K
Intrexon XON:US $ 18.66M 1.34M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Ligand Pharmaceuticals LGND:US $ 12.72M 1.99M
Macrogenics MGNX:US $ 17.16M 1.93M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Pfizer PFE:US $ 2.73B 61M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Veracyte VCYT:US $ 59.54M 39.63M